Formation Bio

@formation__bio

Followers
563
Following
1
Account Insight
Score
23.25%
Index
Health Rate
%
Users Ratio
563:1
Weeks posts
Excited to announce the latest addition to our clinical development pipeline: a first in class anti-CD226 monoclonal antibody targeting autoimmune diseases, licensed from IMIDomics.
31 1
9 months ago
8 0
2 years ago
5 0
2 years ago
6 0
2 years ago
8 0
2 years ago
7 0
2 years ago
6 0
2 years ago
4 0
2 years ago
www.formation.bio
2 0
2 years ago
4 0
2 years ago
Proud to support our teams with paid family leave and flexible PTO. #showusyourleave @theskimm @carlyanddanielle
26 2
4 years ago
Read about our company mission and our recent $156mm Series C fundraise here: https://prn.to/3AYO9sr (and in our bio) @benjamineliu @lintaho
47 0
4 years ago